Koklu, S. Et Al. 2017. Daclatasvir Plus Asunaprevir Dual Therapy for Chronic HCV Genotype 1b Infection: Results of Turkish Early Access Program. ANNALS OF HEPATOLOGY , vol.16, no.1 , 71-76.

Koklu, S., Koksal, I., Akarca, U. S., Balkan, A., Guner, R., Demirezen, A., ... Sahin, M.(2017). Daclatasvir Plus Asunaprevir Dual Therapy for Chronic HCV Genotype 1b Infection: Results of Turkish Early Access Program. ANNALS OF HEPATOLOGY , vol.16, no.1, 71-76.

Koklu, Seyfettin Et Al. "Daclatasvir Plus Asunaprevir Dual Therapy for Chronic HCV Genotype 1b Infection: Results of Turkish Early Access Program," ANNALS OF HEPATOLOGY , vol.16, no.1, 71-76, 2017

Koklu, Seyfettin Et Al. "Daclatasvir Plus Asunaprevir Dual Therapy for Chronic HCV Genotype 1b Infection: Results of Turkish Early Access Program." ANNALS OF HEPATOLOGY , vol.16, no.1, pp.71-76, 2017

Koklu, S. Et Al. (2017) . "Daclatasvir Plus Asunaprevir Dual Therapy for Chronic HCV Genotype 1b Infection: Results of Turkish Early Access Program." ANNALS OF HEPATOLOGY , vol.16, no.1, pp.71-76.

@article{article, author={Seyfettin Koklu Et Al. }, title={Daclatasvir Plus Asunaprevir Dual Therapy for Chronic HCV Genotype 1b Infection: Results of Turkish Early Access Program}, journal={ANNALS OF HEPATOLOGY}, year=2017, pages={71-76} }